(±)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: A comparison of single vs once per week treatment for 5 weeks

Neuropharmacology

Volumn 55, Issue 7, 2008, Pages 1121-1130

  Skelton, Matthew R ^a   Able, Jessica A ^a   Grace, Curtis E ^a   Herring, Nicole R ^a   Schaefer, Tori L ^a   Gudelsky, Gary A ^b   Vorhees, Charles V ^a   Williams, Michael T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Cincinnati water maze; MDMA; Morris water maze; Path integration learning; Spatial learning

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; SEROTONIN; WATER; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; PSYCHEDELIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; CONTROLLED STUDY; DRUG ABUSE; EXPERIMENTAL TEST; HYPERACTIVITY; HYPERTHERMIA; IMPULSIVENESS; LEARNING; LOCOMOTION; MALE; MARBLE BURYING TEST; MAZE TEST; NEUROTRANSMISSION; NONHUMAN; PATH INTEGRATION LEARNING; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; SPATIAL LEARNING; SPATIAL MEMORY; SPRAGUE DAWLEY RAT; SWIMMING; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; MOTOR ACTIVITY; PSYCHOLOGICAL ASPECT; RECOGNITION; TIME;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BODY TEMPERATURE; BODY WEIGHT; HALLUCINOGENS; LEARNING; MALE; MAZE LEARNING; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOGNITION (PSYCHOLOGY); SWIMMING; TIME FACTORS;

EID: 54049154612     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.07.006     Document Type: Article

References (61)

1. Able J.A., Gudelsky G.A., Vorhees C.V., and Williams M.T. 3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol. Psychiatry 59 (2006) 1219-1226
2. Balcombe J.P., Barnard N.D., and Sandusky C. Laboratory routines cause animal stress. Contemp. Top. Lab. Anim. Sci. 43 (2004) 42-51
3. Baumann M.H., Clark R.D., Franken F.H., Rutter J.J., and Rothman R.B. Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience (2008)
4. Baumann M.H., Wang X., and Rothman R.B. 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) 189 (2007) 407-424
5. Blair H.T., and Sharp P.E. Visual and vestibular influences on head-direction cells in the anterior thalamus of the rat. Behav. Neurosci. 110 (1996) 643-660
6. Bolla K.I., McCann U.D., and Ricaurte G.A. Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology 51 (1998) 1532-1537
7. Cain D.P. Prior non-spatial pretraining eliminates sensorimotor disturbances and impairments in water maze learning caused by diazepam. Psychopharmacology (Berl) 130 (1997) 313-319
8. Cho A.K. Ice: a new dosage form of an old drug. Science 249 (1990) 631-634
9. Cho A.K., Melega W.P., Kuczenski R., and Segal D.S. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39 (2001) 161-166
10. Clark R.E., Zola S.M., and Squire L.R. Impaired recognition memory in rats after damage to the hippocampus. J. Neurosci. 20 (2000) 8853-8860
11. Cohen M.A., Skelton M.R., Schaefer T.L., Gudelsky G.A., Vorhees C.V., and Williams M.T. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood. Synapse 57 (2005) 148-159
12. Commins D.L., Vosmer G., Virus R.M., Woolverton W.L., Schuster C.R., and Seiden L.S. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J. Pharmacol. Exp. Ther. 241 (1987) 338-345
13. Cook D., and Kesner R.P. Caudate nucleus and memory for egocentric localization. Behav. Neural Biol. 49 (1988) 332-343
14. Cunningham C.L., Fidler T.L., and Hill K.G. Animal models of alcohol's motivational effects. Alcohol Res. Health 24 (2000) 85-92
15. Dai S., Corrigall W.A., Coen K.M., and Kalant H. Heroin self-administration by rats: influence of dose and physical dependence. Pharmacol. Biochem. Behav. 32 (1989) 1009-1015
16. Derlet R.W., and Heischober B. Methamphetamine: stimulant of the 1990s?. West J. Med. 153 (1990) 625-628
17. EMCDDA. Annual Report 2004: The State of the Drugs Problem in the European Union and Norway (2004), European Monitoring Centre for Drugs and Drug Addiction, Luxembourg
18. Frohardt R.J., Bassett J.P., and Taube J.S. Path integration and lesions within the head direction cell circuit: comparison between the roles of the anterodorsal thalamus and dorsal tegmental nucleus. Behav. Neurosci. 120 (2006) 135-149
19. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy". Pharmacol. Rev. 55 (2003) 463-508
20. Harro J. Long-term partial 5-HT depletion: interference of anxiety and impulsivity?. Psychopharmacology (Berl) 164 (2002) 433-434
21. Herring N.R., Schaefer T.L., Gudelsky G.A., Vorhees C.V., and Williams M.T. Effect of (+)-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology (Berl) 199 (2008) 637-650
22. Irvine R.J., Keane M., Felgate P., McCann U.D., Callaghan P.D., and White J.M. Plasma drug concentrations and physiological measures in 'dance party' participants. Neuropsychopharmacology 31 (2006) 424-430
23. Johnston L.D., O'Malley P.M., Bachamn J.G., and Schulenberg J.E. Monitoring the Future National Survey Results on Drug Use, 1975-2006. Volume I: Secondary School Students. NIH Publication No. 07-6205 (2007), National Institute on Drug Abuse, Bethesda, MD
24. Kalechstein A.D., De La G.R., Mahoney III J.J., Fantegrossi W.E., and Newton T.F. MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl) 189 (2007) 531-537
25. Klugman A., and Gruzelier J. Chronic cognitive impairment in users of 'ecstasy' and cannabis. World Psychiatr. 2 (2003) 184-190
26. Kouimtsidis C., Schifano F., Sharp T., Ford L., Robinson J., and Magee C. Neurological and psychopathological sequelae associated with a lifetime intake of 40,000 ecstasy tablets. Psychosomatics 47 (2006) 86-87
27. Leussis M.P., and Bolivar V.J. Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci. Biobehav. Rev. 30 (2006) 1045-1064
28. Lin J.H. Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics. Drug Metab. Dispos. 26 (1998) 1202-1212
29. Mahmood I. Allometric issues in drug development. J. Pharm. Sci. 88 (1999) 1101-1106
30. McGregor I.S., Gurtman C.G., Morley K.C., Clemens K.J., Blokland A., Li K.M., Cornish J.L., and Hunt G.E. Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology (Berl) 168 (2003) 465-474
31. Mordenti J., and Chappell W. The use of interspecies scaling in toxicokinetics. In: Yacobi A., Kelly J., and Batra V. (Eds). Toxicokinetics in New Drug Development (1989), Pergamon Press, New York 42-96
32. Morgan M.J. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19 (1998) 252-264
33. Morley K.C., Gallate J.E., Hunt G.E., Mallet P.E., and McGregor I.S. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy". Eur. J. Pharmacol. 433 (2001) 91-99
34. Moser E.I., Kropff E., and Moser M.B. Place cells, grid cells, and the brain's spatial representation system. Annu. Rev. Neurosci. (2008)
35. Njung'e K., and Handley S.L. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol. Biochem. Behav. 38 (1991) 63-67
36. Parrott A.C., Lees A., Garnham N.J., Jones M., and Wesnes K. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits. J. Psychopharmacol. 12 (1998) 79-83
37. Piper B.J., Fraiman J.B., and Meyer J.S. Repeated MDMA ("ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding. Dev. Psychobiol. 47 (2005) 145-157
38. Piper B.J., and Meyer J.S. Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period. Pharmacol. Biochem. Behav. 79 (2004) 723-731
39. Potegal M. The caudate nucleus egocentric localization system. Acta Neurobiol. Exp. (Wars.) 32 (1972) 479-494
40. Saadat K.S., Elliott J.M., Green A.R., and Moran P.M. High-dose MDMA does not result in long-term changes in impulsivity in the rat. Psychopharmacology (Berl) 188 (2006) 75-83
41. Scholey A.B., Parrott A.C., Buchanan T., Heffernan T.M., Ling J., and Rodgers J. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Addict. Behav. 29 (2004) 743-752
42. Sharp P.E., Blair H.T., and Cho J. The anatomical and computational basis of the rat head-direction cell signal. Trends Neurosci. 24 (2001) 289-294
43. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., and Dourish C.T. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl) 116 (1994) 56-64
44. Skelton M.R., Blankenmeyer T.L., Gudelsky G.A., Brown-Strittholt C.A., Vorhees C.V., and Williams M.T. Metyrapone attenuates the sequential learning deficits but not monoamine depletions following d,l-fenfluramine administration to adult rats. Synapse 54 (2004) 214-222
45. Skelton M.R., Williams M.T., and Vorhees C.V. Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats. Psychopharmacology (Berl) 189 (2006) 307-318
46. Song P., and Wang X.J. Angular path integration by moving "hill of activity": a spiking neuron model without recurrent excitation of the head-direction system. J. Neurosci. 25 (2005) 1002-1014
47. Sprague J.E., Preston A.S., Leifheit M., and Woodside B. Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol. Behav. 79 (2003) 281-287
48. de la Torre R., and Farre M. Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans. Trends Pharmacol. Sci. 25 (2004) 505-508
49. de la Torre R., Farre M., Roset P.N., Pizarro N., Abanades S., Segura M., Segura J., and Cami J. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther. Drug Monit. 26 (2004) 137-144
50. Uchtenhagen A., Dobler-Mikola A., Steffen T., Gutzwiller F., Blatter R., and Pfeifer S. Prescription of narcotics for heroin addicts: main results of the Swiss National Cohort Study. Medical Prescription of Narcotics (1999), Karger, Basel
51. Viggiano D., Ruocco L.A., and Sadile A.G. Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 27 (2003) 623-637
52. Vorhees C.V. Maze learning in rats: a comparison of performance in two water mazes in progeny prenatally exposed to different doses of phenytoin. Neurotoxicol. Teratol. 9 (1987) 235-241
53. Vorhees C.V., and Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protocol. 1 (2006) 848-858
54. West G.B., Woodruff W.H., and Brown J.H. Allometric scaling of metabolic rate from molecules and mitochondria to cells and mammals. Proc. Natl. Acad. Sci. U S A 99 Suppl. 1 (2002) 2473-2478
55. White C.R., and Seymour R.S. Allometric scaling of mammalian metabolism. J. Exp. Biol. 208 (2005) 1611-1619
56. Williams M.T., Brown C.A., Skelton M.R., Vinks A.A., and Vorhees C.V. Absorption and clearance of +/-3,4-methylenedioxymethamphetamine from the plasma of neonatal rats. Neurotoxicol. Teratol. 26 (2004) 849-856
57. Williams M.T., Moran M.S., and Vorhees C.V. Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Psychopharmacology (Berl) (2003)
58. Williams M.T., Morford L.L., McCrea A.E., Wood S.L., and Vorhees C.V. Administration of d,l-fenfluramine to rats produces learning deficits in the Cincinnati water maze but not the Morris water maze: relationship to adrenal cortical output. Neurotoxicol. Teratol. 24 (2002) 783-796
59. Williams M.T., Vorhees C.V., Boon F., Saber A.J., and Cain D.P. Methamphetamine exposure from postnatal day 11 to 20 causes impairments in both behavioral strategies and spatial learning in adult rats. Brain Res. 958 (2002) 312-321
60. Wolbers T., Wiener J.M., Mallot H.A., and Buchel C. Differential recruitment of the hippocampus, medial prefrontal cortex, and the human motion complex during path integration in humans. J. Neurosci. 27 (2007) 9408-9416
61. Zakzanis K.K., and Campbell Z. Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up. Neurology 66 (2006) 740-741